Welcome To Vagmine Pharma
Welcome to Vagmine Pharma
Vagmine Pharma is an Indian enterprise molded by global aspirations. This has always demanded a preparedness and long- term organizational vision that can encompass the turbulence's and paradoxes of shifting terms and terrain's of business.
Vagmine Pharma privative limited is a manufacturing company and was started in the year 2016 by focusing on intermediates
About Us
Vagmine Pharma was started in the year 2016 as a Private Limited Company to be in the business of Research, Developing, Manufacturing and Marketing of Pharmaceutical Substances for Indian and International markets. Vagmine Pharma began operations with highly committed group of professionals in 2016 in Andhra Pradesh, India
Our Services
Process Development
- Route of synthesis- optimization and validation
- Custom research and manufacturing process
- Scale-up & optimization
- Quantity : 1 gm to 100kgs
- Commercial scale manufacturing services
- Multi step advanced intermediates for API’s
- Analytical method development and validation
- Impurity profiling.
Drug development Support
- Synthesis of intermediates and related chemicals
- Scale up from lab to pilot and pilot to commercialization
- Synthesis of NCE and intermediates
- Synthesis building blocks and scaffolds
Vagmine pharma (BB & Fine chem)
| Catalogue Number | Chemical Name | CASs number |
|---|---|---|
| VP-BB-007 | 6-Chloroanthranilic Acid | 2148-56-3 Cl 434-76-4 F 4389-50-8 Me 53600-33-2 OMe 606-18-8 NO2 |
| VP-BB-008 | 2-Amino-5 chlorobenzoic acid | 635-21-2 | VP-BB-012 | 2,4-Dichloro-5-iodopyrimidine | 13544-44-0 |
| VP-BB-013 | 2-Amino-5-bromopyrimidine | 7752-82-1 |
| VP-BB-029 | 2-Chloropyrimidine | 1722-12-9 |
| VP-BB-035 | 4-Ethyl-5-fluoro 6-hydroxypyrimidine |
137234-87-8 759-67-1 |
| VP-BB-039 | 4,5-Dichloropyrimidin-2-amine | 403854-21-7 |
| VP-BB-042 | 5-Bromo-2,4dichloropyrimidine | 36082-50-5 |
| VP-BB-048 | 5-Bromo-4-chloropyrimidin-2-amine | 1044767-99-8 |
| VP-BB- 050 | 2-Methoxy-4-nitroaniline | 97-52-9 |
| VP-BB-054 | indole-3-carboxylic acid | 771-50-6 |
| VP-BB-055 | 2-Bromopyrimidine | 4595-60-2 |
| VP-BB-060 | 4-bromo-1H-indole | 52488-36-5 |
| VP-BB-064 | cytosine | 971-30-7 |
| VP-BB-067 | 3-Aminophthalic acid | 5434-20-8 |
| VP-BB-073 | 4-Fluoro-2-methoxy 5- nitroaniline | 1075705-01-9 450-91-9 |
| VP-BB-075 | 2-Chloro-6-methylaniline | 87-63-8 |
| VP-BB-077 | Ethyl 3,4-dihydroxybenzoate | 3943-89-3 99-50-3 |
| VP-BB-078 | 4-Chloro-6-ethyl-5-fluoropyrimidine | 137234-74-3 |
| VP-BB-080 | 2,5-Dichloro-3-nitroaniline | 857595-86-9 2213-82-3 5344-44-5 618-86-0 |
| VP-BB-081 | 3-Amino-2,6-dichlorobenzonitrile | 19846-20-9 5866-98-8 55775-98-9 55775-97-8 |
| VP-BB-082 | 5-Methoxy-3-formylindole | 10601-19-1 1006-94-6 |
| VP-BB-083 | 6-Bromoindole | 52415-29-9 7149-70-4 89-62-3 |
| VP-BB-084 | 6-Methoxyindole | 3189-13-7 119-10-8 |
| VP-BB-085 | Indole 2-carboxylic acid ethyl ester And 6 th position substituents | 37750-50-1 4792-67-0 Cl 348-36-7 F 24985-85-1 OH 4792-58-9 OMe |
| VP-BB-086 | Indole 2-carboxylic acid And 6 th position substituents | 1477-50-5 10517-21-2 Cl 399-76-8 F 21598-06-1 OH 4382-54-1 OMe |
| VP-BB-087 | 3-amino-4-methylbenzoic acid | 2458-12-0 |
| VP-BB-088 | Methyl 5-bromo-2,3-diaminobenzoate | 1248541-63-0 636581-61-8 57113-91-4 |
| VP-BB-089 | 5-Bromo-2,4-dichloro-7H pyrrolo[2,3-d]pyrimidine | 900789-14-2 90213-66-4 39929-79-8 56-09-7 |
| VP-BB-090 | 3-Amino-N-cyclopropyl-4 methylbenzamide | 836684-55-0 623155-19-1 303133-89-3 96-98-0 |
Vagmine pharma (Oncology int & BB)
| Catalogue Number | CAAS Number | Chemical name |
|---|---|---|
| VP-OD-001 | 630125-49-4 | 1-bromo-3-nitro-5-trifluoromethyl)benzene |
| VP-OD-002 | 54962-75-3 | 3-Bromo-5-(trifluoromethyl)aniline |
| VP-OD-003 | 641571-11-1 | 3-(4-Methyl-1H-imidazol-1-yl)-5(trifluoromethyl)aniline |
| VP-OD-004 | 1157857-29-8 | 4-methyl-N-(3-(4-methyl-1H-imidazol1-yl)-5-(trifluoromethyl)phenyl)-3nitrobenzamide |
| VP-OD-005 | 915711-42-1 | 3-amino-4-methyl-N-(3-(4-methyl-1H imidazol-1-yl)-5(trifluoromethyl)phenyl)benzamide |
| VP-OD-006 | 123367-26-0 | (E)-3-(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one |
| VP-OD-007 | 1345336-53-9 | 3-guanidino-4-methyl-N-(3-(4-methyl 1H-imidazol-1-yl)-5 (trifluoromethyl)phenyl)benzamide |
| VP-OD-008 | Nilotinib | 4-methyl-N-[3-(4-methyl-1H-imidazol 1-yl)- 5-(trifluoromethyl)phenyl]-3- [(4 pyridin-3-ylpyrimidin-2-yl) amino]benzamide |
| VP-OD-009 | 106874-28-6 | (3S,8R,9S,10R,13S,14S)-17-bromo 10,13-dimethyl 2,3,4,7,8,9,10,11,12,13,14,15 dodecahydro-1H cyclopenta[a]phenanthren-3-ol |
| VP-OD-010 | 154229-19-3 | Abiraterone |
| VP-OD-011 | 154229-18-2 | abiraterone acetate |
| VP-OD-012 | 77059-28-0 | (3S,8R,9S,10R,13S,14S)-17-iodo 10,13-dimethyl 2,3,4,7,8,9,10,11,12,13,14,15 dodecahydro-1H cyclopenta[a]phenanthren-3-ol |
| VP-OD-013 | 279673-09-5 | 5-Deoxy-d-ribofuranose |
| VP-OD-014 | 66335-38-4 | 4-amino-1-(3,4-dihydroxy-5 methyltetrahydrofuran-2-yl)-5 fluoropyrimidin-2(1H)-one |
| VP-OD-015 | 154361-50-9 | Capecitabine |
| VP-OD-016 | 861445-88-7 | (4R,5R)-3,3-difluoro-5 (hydroxymethyl)tetrahydrofuran-2,4 diol |
| VP-OD-017 | 14631-20-0 | N-(2-oxo-1,2-dihydropyrimidin-4 yl)acetamide |
| VP-OD-018 | 134790-39-9 | (2R,3R,5R)-5-(4-amino-2 oxopyrimidin-1(2H)-yl)-2 ((benzoyloxy)methyl)-4,4 difluorotetrahydrofuran-3-yl benzoate |
| VP-OD-019 | 95058-81-4 | Gemcitabine |
| VP-OD-020 | 122111-03-9 | gemcitabine hydrochloride |
| VP-OD-021 | 50-18-0 | (RS)-N,N-bis(2-chloroethyl)-1,3,2 oxazaphosphinan-2-amine 2-oxide |
| VP-OD-022 | 04342-03-4 | (E)-5-(3,3-dimethyltriaz-1-en-1-yl)-1H imidazole-4-carboxamide |
| VP-OD-023 | 7/6/4998 | 4,5-dimethoxy-2-nitrobenzoic acid |
| VP-OD-024 | 31839-21-1 | 2-amino-5-hydroxy-4-methoxybenzoic acid |
| VP-OD-025 | 179688-52-9 | 7-methoxyquinazoline-4,6-diol |
| VP-OD-026 | 574745-97-4 | 4-chloro-7-methoxyquinazolin-6-ol |
| VP-OD-027 | 5653-40-7 | 2-Amino-4,5-dimethoxybenzoic acid |
| VP-OD-028 | 199327-61-2 | 7-methoxy-6-(3 morpholinopropoxy)quinazolin-4(3H)one |
| VP-OD-029 | 199327-59-8 | 4-(3-((4-chloro-7-methoxyquinazolin-6 yl)oxy)propyl)morpholine |
| VP-OD-030 | 367-21-5 | 3-chloro-4-fluoroaniline |
| VP-OD-031 | 184475-35-2 | gefitinib |
| VP-OD-032 | 7357-67-7 | 4-(3-chloropropyl)morpholine |
| VP-OD-033 | 20191-74-6 | 2-ethyl-5-nitroaniline |
| VP-OD-034 | 6494-19-5 | 2,3-dimethyl-6-nitro-2H-indazole |
| VP-OD-035 | 444731-72-0 | 2,3-dimethyl-2H-indazol-6-amine |
| VP-OD-036 | 1376676-65-1 | N,2,3-trimethyl-2H-indazol-6-amine |
| VP-OD-037 | 3934-20-1 | 2,4-Dichloropyrimidine |
| VP-OD-038 | 444731-75-3 | N-(2-chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine |
| VP-OD-039 | 9/7/6973 | 5-amino-2-methylbenzenesulfonamide |
| VP-OD-040 | 635702-64-6 | Pazopanib Hydrochloride |
| VP-OD-041 | 619-42-1 | methyl 4-bromobenzoate |
| VP-OD-042 | 106200-41-3 | methyl 4-(4-oxobutyl)benzoate |
| VP-OD-043 | 155405-79-1 | methyl 4-(3-bromo-4-oxobutyl)benzoate |
| VP-OD-044 | 56-06-4 | 2,4-Diamino-6-hydroxypyrimidine |
| VP-OD-045 | 155405-80-4 | methyl 4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoate |
| VP-OD-046 | 137281-39-1 | 4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoic acid |
| VP-OD-047 | 1118-89-4 | diethyl L-glutamate |
| VP-OD-048 | 165049-28-5 | diethyl (4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate |
| VP-OD-049 | 137281-23-3 | Pemetrexed |
| VP-OD-050 | 5470-22-4 | 4-chloropicolinic acid |
| VP-OD-051 | 882167-77-3 | 220000-87-3 4-chloro-N-methylpicolinamide |
| VP-OD-052 | 2750398-63-9 | 4-(4-acetamidophenoxy)-N-methylpicolinamide |
| VP-OD-053 | 50528-86-4 | 1-chloro-4-isocyanato-2-(trifluoromethyl)benzene |
| VP-OD-054 | 284461-73-0 | 475207-59-1 Sorafenib |
| VP-OD-055 | 152460-10-1 | Imatinib amine (or) imatinib base |
| VP-OD-056 | 106261-49-8 | Imatinib acid |
| VP-OD-057 | 24666-56-6 | 3-aminopiperidine-2,6-dione hydrochloride |
| VP-OD-058 | 2931502-01-9 | methyl 3-amino-2(bromomethyl)benzoate |
| VP-OD-059 | 191732-72-6 | 3-(4-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione |
| VP-OD-060 | 849217-48-7 | 1-((4-fluorophenyl)carbamoyl)cyclopropanecarboxylic acid |
| VP-OD-061 | 1245931-90-1 | ethyl 1-((4-fluorophenyl)carbamoyl)cyclopropanecarboxylate |
| VP-OD-062 | 190728-25-7 | 4-((6,7-dimethoxyquinolin-4-yl)oxy)aniline |
| VP-OD-063 | 849217-68-1 | N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| VP-OD-064 | 35654-56-9 | 4-chloro-6,7-dimethoxyquinoline |
| VP-OD-065 | 65473-13-4 | N-methyl-1-(naphthalen-1-yl)methanamine hydrochloride |